Megestrol Acetate Suspension
Product Images NDC 68788-8714

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Megestrol Acetate (NDC 68788-8714). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Preferred Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Formula (63aedf9e 8b0a 4dcc 8fa6 5c7dc4c776d3 01)

Chemical Formula (63aedf9e 8b0a 4dcc 8fa6 5c7dc4c776d3 01)
Chemical structure diagram of megestrol acetate, USP, showing the molecular framework with labeled functional groups and bonds.*
FDA Label Image

Trial 1 (63aedf9e 8b0a 4dcc 8fa6 5c7dc4c776d3 02)

Trial 1 (63aedf9e 8b0a 4dcc 8fa6 5c7dc4c776d3 02)
A line graph titled 'TRIAL 1' depicting mean weight change in pounds over weeks 0, 4, 8, and 12, comparing dosages of 800 mg, 400 mg, 100 mg, and placebo for Megestrol Acetate oral suspension. The y-axis ranges from -3 to 12 pounds, and the x-axis marks weeks. The graph shows weight increase trends for different dosages and a decrease with placebo.*
FDA Label Image

Trial 2 (63aedf9e 8b0a 4dcc 8fa6 5c7dc4c776d3 03)

Trial 2 (63aedf9e 8b0a 4dcc 8fa6 5c7dc4c776d3 03)
A line graph titled TRIAL 2 showing mean weight change in pounds over 12 weeks. The x-axis represents weeks (0, 4, 8, 12) and the y-axis shows weight change from -3 to 12 pounds. Two lines compare weight changes for 800 mg and placebo groups, with the 800 mg group showing an increasing trend and the placebo group remaining near zero after a slight increase.*
FDA Label Image

Megestrol Acetate Oral Suspension Usp 40mgml (63aedf9e 8b0a 4dcc 8fa6 5c7dc4c776d3 04)

Megestrol Acetate Oral Suspension Usp 40mgml (63aedf9e 8b0a 4dcc 8fa6 5c7dc4c776d3 04)
Megestrol Acetate Oral Suspension USP 40 mg/mL label with black text on a white and yellow background. The label includes directions for use in both English and Spanish. It lists the manufacturer as Strides Pharma Inc. but the labeler is Preferred Pharmaceuticals Inc. It contains a caution about federal law prohibiting drug transfer and details about the suspension's ingredients and storage conditions.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.